There were 89.9% cases of adverse events after injection, of which 32.1% had 5 or more events; There were no serious events requiring hospitalization, the main events were muscle pain (56.2%), mild fever (51.6%), fatigue (66.2%), swelling and pain at injection site (30.8%), headache (55.8%).